FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002364985> ?p ?o ?g. }

• W2002364985 endingPage "301" @default.
• W2002364985 startingPage "299" @default.
• W2002364985 abstract "Immune intervention at diagnosis of type 1 diabetes (T1D) aims to prevent or reverse the disease by blocking autoimmunity, thereby preserving/restoring β-cell mass and function. Recent clinical trials of non-specific and of antigen-specific immune therapies have demonstrated the feasibility of modulation of islet-specific autoimmunity in patients with partial prevention of loss of insulin secretion. In a series of review articles published in this issue of the journal, some of the most promising approaches of immune intervention in T1D are presented. Here we outline the rationale of such interventions and future prospects in this area. Copyright © 2009 John Wiley & Sons, Ltd. Insulin therapy in type 1 diabetes (T1D) rescues the patient from a certain death but not cure the disease. The goal of any therapeutic intervention in T1D is the preservation of insulin-secreting cells; this is achieved by the abrogation of pathogenic reactivity to beta cell autoantigens while preserving full capacity to generate a normal immune response against foreign antigens. Although several therapeutic candidates have been investigated in experimental models of T1D many of which showed promising results, a successful extrapolation of these findings to human T1D has proved to be difficult. In part, this failure results from the considerable disease heterogeneity associated with diverse genetic and non-genetic disease determinants and the spectrum of clinical phenotype at diagnosis. Thus, a younger age at onset is associated with stronger genetic susceptibility, more intense immune response to β-cell antigens, shorter duration of symptoms, more severe metabolic derangement at diagnosis and a more rapid rate of β-cell-destruction 1-3. Therefore, designing therapies that would be effective in all clinical settings is definitely challenging. In this issue five different approaches are discussed ranging from antigen-specific therapies [DiaPep277 and glutamic acid decarboxylase(GAD)], to non-antigen-specific immunoregulation (anti-CD3) and to anti-inflammatory (anti-IL1 receptor antagonist). These approaches are currently being tested in large international multicenter trials, and all of them use very similar outcome in terms of a beneficial effect (C-peptide secretion as evidence of a therapeutic effect on restoration of β-cell function). The authors have been asked to follow a similar format in presenting their approaches so that the reader can easily compare them in terms of rationale and therapeutic goals." @default.
• W2002364985 created "2016-06-24" @default.
• W2002364985 creator A5039395009 @default.
• W2002364985 creator A5087265840 @default.
• W2002364985 date "2009-05-01" @default.
• W2002364985 modified "2023-10-18" @default.
• W2002364985 title "New prospects for immunotherapy at diagnosis of type 1 diabetes" @default.
• W2002364985 cites W1983023441 @default.
• W2002364985 cites W2024378513 @default.
• W2002364985 cites W2029115602 @default.
• W2002364985 cites W2041637201 @default.
• W2002364985 cites W2044679483 @default.
• W2002364985 cites W2047627851 @default.
• W2002364985 cites W2053650809 @default.
• W2002364985 cites W2074463323 @default.
• W2002364985 cites W2081044418 @default.
• W2002364985 cites W2111457140 @default.
• W2002364985 cites W2149513114 @default.
• W2002364985 cites W4230364018 @default.
• W2002364985 doi "https://doi.org/10.1002/dmrr.970" @default.
• W2002364985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19405079" @default.
• W2002364985 hasPublicationYear "2009" @default.
• W2002364985 type Work @default.
• W2002364985 sameAs 2002364985 @default.
• W2002364985 citedByCount "8" @default.
• W2002364985 countsByYear W20023649852013 @default.
• W2002364985 countsByYear W20023649852022 @default.
• W2002364985 countsByYear W20023649852023 @default.
• W2002364985 crossrefType "journal-article" @default.
• W2002364985 hasAuthorship W2002364985A5039395009 @default.
• W2002364985 hasAuthorship W2002364985A5087265840 @default.
• W2002364985 hasConcept C126322002 @default.
• W2002364985 hasConcept C134018914 @default.
• W2002364985 hasConcept C147483822 @default.
• W2002364985 hasConcept C203014093 @default.
• W2002364985 hasConcept C2777701055 @default.
• W2002364985 hasConcept C2779134260 @default.
• W2002364985 hasConcept C2779306644 @default.
• W2002364985 hasConcept C2780130043 @default.
• W2002364985 hasConcept C2781232474 @default.
• W2002364985 hasConcept C535046627 @default.
• W2002364985 hasConcept C555293320 @default.
• W2002364985 hasConcept C60644358 @default.
• W2002364985 hasConcept C71924100 @default.
• W2002364985 hasConcept C86803240 @default.
• W2002364985 hasConcept C8891405 @default.
• W2002364985 hasConceptScore W2002364985C126322002 @default.
• W2002364985 hasConceptScore W2002364985C134018914 @default.
• W2002364985 hasConceptScore W2002364985C147483822 @default.
• W2002364985 hasConceptScore W2002364985C203014093 @default.
• W2002364985 hasConceptScore W2002364985C2777701055 @default.
• W2002364985 hasConceptScore W2002364985C2779134260 @default.
• W2002364985 hasConceptScore W2002364985C2779306644 @default.
• W2002364985 hasConceptScore W2002364985C2780130043 @default.
• W2002364985 hasConceptScore W2002364985C2781232474 @default.
• W2002364985 hasConceptScore W2002364985C535046627 @default.
• W2002364985 hasConceptScore W2002364985C555293320 @default.
• W2002364985 hasConceptScore W2002364985C60644358 @default.
• W2002364985 hasConceptScore W2002364985C71924100 @default.
• W2002364985 hasConceptScore W2002364985C86803240 @default.
• W2002364985 hasConceptScore W2002364985C8891405 @default.
• W2002364985 hasIssue "4" @default.
• W2002364985 hasLocation W20023649851 @default.
• W2002364985 hasLocation W20023649852 @default.
• W2002364985 hasOpenAccess W2002364985 @default.
• W2002364985 hasPrimaryLocation W20023649851 @default.
• W2002364985 hasRelatedWork W1831490185 @default.
• W2002364985 hasRelatedWork W2035967193 @default.
• W2002364985 hasRelatedWork W2048680767 @default.
• W2002364985 hasRelatedWork W2170151170 @default.
• W2002364985 hasRelatedWork W2936883434 @default.
• W2002364985 hasRelatedWork W3095781503 @default.
• W2002364985 hasRelatedWork W3213488669 @default.
• W2002364985 hasRelatedWork W4235553603 @default.
• W2002364985 hasRelatedWork W4285269086 @default.
• W2002364985 hasRelatedWork W4324121871 @default.
• W2002364985 hasVolume "25" @default.
• W2002364985 isParatext "false" @default.
• W2002364985 isRetracted "false" @default.
• W2002364985 magId "2002364985" @default.
• W2002364985 workType "article" @default.